| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $349.7M | $350.4M | $362.6M |
| YoY Revenue Growth % | -0.2% | -3.4% | — |
| Gross Profit | $279.1M | $280.7M | — |
| Gross Margin % | 79.8% | 80.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $150.2M | $149.4M | $147.2M |
| Operating Margin % | 43.0% | 42.6% | 40.6% |
| Net Income (GAAP) | $84.5M | $89.4M | $77.3M |
| EBITDA (Normalized) | $174.4M | $176.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $136.1M | $121.7M | $114.1M |
| Capital Expenditures (CapEx) | $30.2M | $33.4M | — |
| Free Cash Flow (FCF) | $105.9M | $88.3M | $114.1M |
| FCF Margin % | 30.3% | 25.2% | 31.5% |
| Return on Invested Capital (ROIC %) | 24.2% | 25.6% | — |
| Cash & Short-Term Equivalents | $74.7M | $33.5M | — |
| Total Debt (Short + Long Term) | $551.3M | $574.1M | — |
| Total Stockholders' Equity | $13.8M | -$79.5M | — |